Insights

Expanding Capabilities Cytovance Biologics is actively expanding its facility footprint and technological partnerships, creating opportunities to target clients seeking scalable and diverse biomanufacturing solutions, especially in mammalian and microbial expression systems.

Innovative Collaborations Recent strategic alliances with companies like PolyPeptide, Excellgene, and Vectron Biosolutions highlight Cytovance's focus on enhancing peptide development, cell line engineering, and strain customization, presenting prospects for partners with complex biologic or peptide projects.

Emerging Oncology Focus The company’s development of a breast cancer vaccine positions it as a potential partner for clients in oncology research and vaccine production, opening avenues for collaborations in personalized and large-scale vaccine manufacturing.

Diverse Product Portfolio Cytovance’s broad expertise in biosimilars, cytokines, enzymes, antibodies, and vaccines offers numerous cross-selling opportunities with biotech firms seeking comprehensive development and manufacturing support for large molecule therapeutics.

Growing Market Presence With a revenue range of up to $250 million and recent facility and operational expansions, Cytovance is well-positioned to attract mid-market biotech firms and large pharmaceutical companies looking for reliable CDMO partners to accelerate their product timelines.

Cytovance Biologics Tech Stack

Cytovance Biologics uses 8 technology products and services including D2L Brightspace, Sucuri, HubSpot Cookie Policy Banner, and more. Explore Cytovance Biologics's tech stack below.

  • D2L Brightspace
    Communication And Collaboration
  • Sucuri
    Content Delivery Network
  • HubSpot Cookie Policy Banner
    Cookie Compliance
  • jQuery
    Javascript Libraries
  • Microsoft Word
    Office Suites
  • Smartsheet
    Project Management
  • Adobe Acrobat DC
    Rich Text Editors
  • Adobe Creative Suite
    Visualisation Software

Media & News

Cytovance Biologics's Email Address Formats

Cytovance Biologics uses at least 1 format(s):
Cytovance Biologics Email FormatsExamplePercentage
FLast@cytovance.comJDoe@cytovance.com
92%
Last.First@cytovance.comDoe.John@cytovance.com
4%
LFirst@cytovance.comDJohn@cytovance.com
2%
Last@cytovance.comDoe@cytovance.com
2%

Frequently Asked Questions

Where is Cytovance Biologics's headquarters located?

Minus sign iconPlus sign icon
Cytovance Biologics's main headquarters is located at 800 Research Parkway Oklahoma City, Oklahoma 73104 United States. The company has employees across 2 continents, including North AmericaAsia.

What is Cytovance Biologics's phone number?

Minus sign iconPlus sign icon
You can contact Cytovance Biologics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cytovance Biologics's official website and social media links?

Minus sign iconPlus sign icon
Cytovance Biologics's official website is cytovance.com and has social profiles on LinkedInCrunchbase.

How much revenue does Cytovance Biologics generate?

Minus sign iconPlus sign icon
As of April 2026, Cytovance Biologics's annual revenue is estimated to be $27M.

What is Cytovance Biologics's SIC code NAICS code?

Minus sign iconPlus sign icon
Cytovance Biologics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cytovance Biologics have currently?

Minus sign iconPlus sign icon
As of April 2026, Cytovance Biologics has approximately 191 employees across 2 continents, including North AmericaAsia. Key team members include Chief Executive Officer: P. Z.Chief Commercial Officer (cco): A. S.Chief Financial Officer: S. W.. Explore Cytovance Biologics's employee directory with LeadIQ.

What industry does Cytovance Biologics belong to?

Minus sign iconPlus sign icon
Cytovance Biologics operates in the Biotechnology Research industry.

What technology does Cytovance Biologics use?

Minus sign iconPlus sign icon
Cytovance Biologics's tech stack includes D2L BrightspaceSucuriHubSpot Cookie Policy BannerjQueryMicrosoft WordSmartsheetAdobe Acrobat DCAdobe Creative Suite.

What is Cytovance Biologics's email format?

Minus sign iconPlus sign icon
Cytovance Biologics's email format typically follows the pattern of FLast@cytovance.com. Find more Cytovance Biologics email formats with LeadIQ.

How much funding has Cytovance Biologics raised to date?

Minus sign iconPlus sign icon
As of April 2026, Cytovance Biologics has raised $20M in funding. The last funding round occurred on Oct 28, 2014 for $20M.

When was Cytovance Biologics founded?

Minus sign iconPlus sign icon
Cytovance Biologics was founded in 2003.

Cytovance Biologics

Biotechnology ResearchOklahoma, United States51-200 Employees

Streamline your biomanufacturing programs with Cytovance Biologics! Born from a decades-long history in drug development, we believe in creating a healthier world where every biologic’s path to commercialization is advanced by a CDMO partner that delivers ingenuity end-to-end. Whether your large molecule product needs the flexibility of a customized approach or the efficiency of a predetermined platform process, Team Cytovance has the deep expertise in microbial and mammalian expression systems to support your scale-up at every stage.

From early needs like cell line development and strain selection to cGMP manufacturing for clinical and commercial production, our team is your team. Together, we will guide your asset through the complexities of manufacturing and deliver it to its next milestone. With a >97% batch success rate and quality, scalability, and reproducibility top of mind, we bring a range of therapeutic proteins and antibodies to the clinic, including:

● Biosimilars
● Cytokines
● Enzymes/Hormones
● Fusion Proteins
● Bispecific, Fragment, and Monoclonal Antibodies
● Recombinant Protein
● Vaccines
● And More

Section iconCompany Overview

Headquarters
800 Research Parkway Oklahoma City, Oklahoma 73104 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2003
Employees
51-200

Section iconFunding & Financials

  • $20M

    Cytovance Biologics has raised a total of $20M of funding over 2 rounds. Their latest funding round was raised on Oct 28, 2014 in the amount of $20M.

  • $100M$250M

    Cytovance Biologics's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $20M

    Cytovance Biologics has raised a total of $20M of funding over 2 rounds. Their latest funding round was raised on Oct 28, 2014 in the amount of $20M.

  • $100M$250M

    Cytovance Biologics's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.